Globo can- estáticas câncer oral no Brasil

Prévia do material em texto

Brazil
Source: Globocan 2018
Summary statistic 2018
Males Females Both sexes
Population 103 599 314 107 268 645 210 867 959
Number of new cancer cases 278 607 280 764 559 371
Age-standardized incidence rate (World) 240.9 201.5 217.2
Risk of developing cancer before the age of 75 years (%) 24.5 19.6 21.8
Number of cancer deaths 129 134 114 454 243 588
Age-standardized mortality rate (World) 109.7 77.9 91.3
Risk of dying from cancer before the age of 75 years (%) 11.2 8.1 9.5
5-year prevalent cases 586 693 720 427 1 307 120
Top 5 most frequent cancers excluding non-melanoma skin cancer
(ranked by cases)
Prostate 
Colorectum 
Lung 
Stomach 
Bladder
Breast 
Colorectum 
Thyroid 
Cervix uteri 
Lung
Breast 
Prostate 
Colorectum 
Lung 
Thyroid
Number of new cases in 2018, both sexes, all ages
Total: 559 371
Breast
85 620 (15.3%)
Prostate
84 992 (15.2%)
Colorectum
51 783 (9.3%)
Lung
34 511 (6.2%)
Thyroid
21 470 (3.8%)
Other cancers
280 995 (50.2%)
Number of new cases in 2018, males, all ages
Total: 278 607
Prostate
84 992 (30.5%)
Colorectum
24 737 (8.9%)
Lung
19 169 (6.9%)
Stomach
12 340 (4.4%)
Bladder
9 127 (3.3%)
Other cancers
128 242 (46%)
Number of new cases in 2018, females, all ages
Total: 280 764
Breast
85 620 (30.5%)
Colorectum
27 046 (9.6%)
Thyroid
16 901 (6%)
Cervix uteri
16 298 (5.8%)
Lung
15 342 (5.5%)
Other cancers
119 557 (42.6%)
Geography
 
Numbers at a glance
Total population
210867959
Number of new cases
559371
Number of deaths
243588
Number of prevalent cases (5-year)
1307120
Data source and methods
Incidence
Country-specific data source: Cancer Registry of Aracaju,
Barretos Cancer Registry, Cancer Registry of Curitiba,
Espirito Santo Cancer Registry, Florianopolis Cancer
Registry , Cancer Registry of Goiânia, Jau Cancer Registry,
Cancer Registry of João Pessoa, Pocos de Caldas Cancer
Registry, Recife Cancer Registry, Roraima Cancer Registry,
Cancer Registry of São Paulo City 
Method: Estimated from national mortality estimates by
modelling, using mortality:incidence ratios derived from
country-specific cancer registry data
Mortality
Country-specific data source: National (WHO) 
Method: National rates projected to 2018
Prevalence
Computed using sex-; site- and age-specific incidence to
1-;3- and 5-year prevalence ratios from Nordic countries for
the period (2000-2009), and scaled using Human
Development Index (HDI) ratios.
The Global Cancer Observatory - All Rights Reserved - May, 2019. Page 1
Brazil
Source: Globocan 2018
Incidence, Mortality and Prevalence by cancer site
New cases Deaths 5-year prevalence (all ages)
Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop.
Breast 85 620 1 15.3 6.78 18 442 2 7.6 1.40 262 226 244.46
Prostate 84 992 2 15.2 9.29 16 730 3 6.9 1.09 184 139 177.74
Lung 34 511 3 6.2 1.55 31 856 1 13.1 1.44 32 583 15.45
Colon 27 957 4 5.0 1.20 15 344 5 6.3 0.60 66 182 31.39
Thyroid 21 470 5 3.8 0.85 1 009 24 0.41 0.04 73 766 34.98
Rectum 21 139 6 3.8 0.94 8 524 10 3.5 0.34 53 856 25.54
Stomach 20 927 7 3.7 0.90 15 796 4 6.5 0.67 28 084 13.32
Cervix uteri 16 298 8 2.9 1.26 8 079 11 3.3 0.62 46 858 43.68
Bladder 13 537 9 2.4 0.57 4 938 15 2.0 0.16 37 187 17.64
Non-Hodgkin lymphoma 12 887 10 2.3 0.53 5 256 14 2.2 0.21 35 060 16.63
Pancreas 12 594 11 2.3 0.52 11 858 6 4.9 0.49 7 820 3.71
Liver 12 463 12 2.2 0.54 11 797 7 4.8 0.51 8 879 4.21
Brain, nervous system 12 304 13 2.2 0.51 10 711 8 4.4 0.46 31 084 14.74
Oesophagus 11 405 14 2.0 0.52 9 761 9 4.0 0.44 10 635 5.04
Leukaemia 11 182 15 2.0 0.43 7 917 12 3.3 0.29 29 530 14.00
Kidney 10 688 16 1.9 0.48 4 084 18 1.7 0.17 25 625 12.15
Lip, oral cavity 10 457 17 1.9 0.46 4 316 16 1.8 0.19 28 270 13.41
Corpus uteri 9 105 18 1.6 0.83 2 472 22 1.0 0.22 28 740 26.79
Larynx 7 947 19 1.4 0.38 5 360 13 2.2 0.26 22 036 10.45
Melanoma of skin 7 407 20 1.3 0.30 2 078 23 0.85 0.08 21 557 10.22
Ovary 6 686 21 1.2 0.52 4 180 17 1.7 0.33 17 184 16.02
Multiple myeloma 5 656 22 1.0 0.26 3 682 20 1.5 0.16 12 672 6.01
Gallbladder 4 717 23 0.84 0.19 3 849 19 1.6 0.16 4 941 2.34
Oropharynx 4 629 24 0.83 0.20 2 936 21 1.2 0.13 13 539 6.42
Hodgkin lymphoma 3 794 25 0.68 0.13 688 26 0.28 0.03 13 250 6.28
Testis 3 760 26 0.67 0.25 477 30 0.20 0.03 13 230 12.77
Anus 2 687 27 0.48 0.09 614 27 0.25 0.02 6 774 3.21
Penis 1 840 28 0.33 0.13 507 29 0.21 0.04 5 381 5.19
Vulva 1 748 29 0.31 0.12 578 28 0.24 0.03 4 790 4.47
Hypopharynx 1 496 30 0.27 0.07 785 25 0.32 0.04 2 258 1.07
Salivary glands 1 462 31 0.26 0.06 452 32 0.19 0.02 3 418 1.62
Nasopharynx 1 146 32 0.20 0.05 455 31 0.19 0.02 3 366 1.60
Kaposi sarcoma 778 33 0.14 0.03 137 34 0.06 0.00 2 130 1.01
Vagina 543 34 0.10 0.04 141 33 0.06 0.01 1 508 1.41
Mesothelioma 196 35 0.04 0.01 119 35 0.05 0.01 202 0.10
All cancer sites 559 371 - - 21.77 243 588 - - 9.52 1 307 120 619.88
Age-standardized (World) incidence rates per sex, top 10 cancers
020406080 0 20 40 60 80
Prostate
Breast
Lung
Colorectum
Thyroid
Stomach
Cervix uteri
Bladder
Non-Hodgkin lymphoma
Brain, nervous system
74.0
16.4
9.5
3.8
10.6
7.7
6.5
5.7
62.9
10.5
10.2
13.1
5.8
12.2
2.9
4.0
4.5
ASR (World) per 100 000
Males Females
Age-standardized (World) incidence and mortality rates, top 10 cancers
020406080 0 20 40 60 80
Prostate
Breast
Colorectum
Lung
Cervix uteri
Thyroid
Stomach
Corpus uteri
Non-Hodgkin lymphoma
Brain, nervous system
74.0
62.9
19.6
13.0
12.2
8.6
7.9
6.7
5.2
5.0
13.6
13.0
9.0
12.0
5.8
0.40
5.9
1.7
2.0
4.3
ASR (World) per 100 000
Incidence Mortality
The Global Cancer Observatory - All Rights Reserved - May, 2019. Page 2